They will be stringent with their approvals
Numerous GLP-1 receptor-targeting drugs have been investigated in clinical studies for various indications, including type 2 diabetes and obesity (accounts for 70% of the total studies), non-alcoholic steatohepatitis, Alzheimer's disease, and Parkinson's disease
This extends half-life from minutes to ~165 hours, allowing weekly administration in research
Compounded semaglutide might be an option if your provider feels the standard, off-the-shelf version isnt the right fit
Terzepatide, another GLP-1 but also with GIP activation, is also being used by many young women desiring weight loss. Given the uncertainties, Hynes suggested, There is also the option of telling them not to take it, as there could be potential risks in childbearing ages. Yet she also acknowledges that as more women experience weight loss with these medications, unintended pregnancies may occur
Beyond standard tirzepatide monitoring (A1c, kidney function, lipids), autoimmune patients should track disease-specific inflammatory markers at baseline, 4 weeks, 12 weeks, and quarterly thereafter